Lexicon Pharmaceuticals Selects Medidata to Aid in Advancing Phase IIb Trial of Non-Opioid Drug for Neuropathic Pain

We, Medidata, use cookies to give you the best experience on our websites by: measuring their audience and improving their performance, by providing you with content and proposals that correspond to your interactions, by serving ads that are relevant to your interests and by allowing you to share content on social networks.

Your preferences will be kept for 6 months and you can change them at any time by clicking on the "Manage my cookies preferences" link in the footer of each webpage. To learn more about how this site uses cookies, please visit our privacy policy.